FDA Drug Recalls

Recalls / Class III

Class IIID-0096-2022

Product

Cetirizine hydrochloride, 10 mg tablets, 90-count bottle, Distributed by: A-S Medications Solutions, Libertyville, IL 60048, Mfg: Major Pharmaceuticals, Livonia, MI 48152, NDC: 50090-5510-3

Brand name
Cetirizine
Generic name
Cetirizine Hydrochloride
Active ingredient
Cetirizine Hydrochloride
Route
Oral
NDC
50090-5510
FDA application
ANDA078336
Affected lot / code info
Lot #: 1256330

Why it was recalled

Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.

Recalling firm

Firm
A-S Medication Solutions LLC.
Manufacturer
A-S Medication Solutions
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
2401 Commerce Dr, N/A, Libertyville, Illinois 60048-4464

Distribution

Quantity
72 bottles
Distribution pattern
FL, IN, MN, WI

Timeline

Recall initiated
2021-10-05
FDA classified
2021-11-05
Posted by FDA
2021-11-17
Terminated
2022-08-12
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0096-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Cetirizine · FDA Drug Recalls